Pier Giorgio Mastroberardino, PhD, is a principal investigator at the Erasmus Medical Center Rotterdam and an associate professor at the University of L'Aquila, where he investigates the molecular mechanisms underlying Parkinson’s disease (PD). His research focuses on how age-related alterations in DNA damage and repair impact metabolism, and mitochondrial function and on how these elements contribute to PD progression. With more than 20 years of experience, Dr. Mastroberardino integrates a broad spectrum of cellular, molecular biological and bioinformatics approaches to unravel the complex interplay between genomic instability, metabolism and disease. His team leverages diverse experimental systems, including patient-derived cells and preclinical models, to uncover disease mechanisms, novel biomarkers and therapeutic targets. Dr. Mastroberardino’s research aims to bridge fundamental science with innovative clinical applications. He holds a Global Executive Master degree in Business Administration and is actively engaged in interactions with the private sector and technology transfer.